The prices outpatients have to pay for purchasing medicines in Armenia

The prices outpatients have to pay for purchasing medicines in Armenia

Bibliographic Details
Main Authors:	Irina Kazaryan, Anahit Sevikyan, Margarit Melikyan
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2015-12-01
Series:	Journal of Pharmaceutical Policy and Practice
Subjects:	Nicotine Omeprazole Fluconazole Ceftriaxone Amlodipine
Online Access:	https://www.tandfonline.com/doi/10.1186/2052-3211-8-S1-P20

Similar Items

A Drug Content, Stability Analysis, and Qualitative Assessment of Pharmacists’ Opinions of Two Exemplar Extemporaneous Formulations
by: Melissa Kirkby, et al.
Published: (2020-07-01)

Availability and affordability of medicines for children
by: Irina Kazaryan, et al.
Published: (2015-12-01)

Cryostructuring of Polymeric Systems: 64. Preparation and Properties of Poly(vinyl alcohol)-Based Cryogels Loaded with Antimicrobial Drugs and Assessment of the Potential of Such Gel Materials to Perform as Gel Implants for the Treatment of Infected Wounds
by: Olga Yu. Kolosova, et al.
Published: (2023-01-01)

Avaliação do efeito antiparasitário do omeprazol na prevenção do desenvolvimento de lesões cutâneas em hamsters infectados por Leishmania brasiliensis Evaluation of omeprazole's antiparasitary effect preventing the development of cutaneous lesions due to Leishmania brasiliensis in hamsters
by: Hélio Amante Miot, et al.
Published: (2005-12-01)

Effects of different enantiomers of amlodipine on lipid profiles and vasomotor factors in atherosclerotic rabbits
by: Zhang Jing, et al.
Published: (2021-09-01)

Effect of omeprazole on the hypotensive efficacy of amlodipine depending on the genetic characteristics of patients
by: M. N. Dorofeeva, et al.
Published: (2018-09-01)

Comparative Study Between the Efficacies of Vonoprazan Versus Omeprazole in Patients with Gastroesophageal Reflux Disease
by: Mohammed Mahdi, et al.
Published: (2023-01-01)

Hipomagnesemia secundária ao uso crônico de Inibidores de Bomba de Prótons: Relato de Caso
by: Renan F. F. Nunes, et al.
Published: (2015-04-01)

Sociodemographic and clinical profile of elderly people chronic users of omeprazole attending the basic health network / Perfil sociodemográfico e clínico de idosos usuários crônicos de omeprazol na rede básica de saúde
by: Christiane de Fátima Colet, et al.
Published: (2019-07-01)

Reducing dyspeptic symptoms in children: proton pump inhibitor vs. H2 receptor antagonist
by: Tien Budi Febriani, et al.
Published: (2014-08-01)

First Pediatric Outpatient Parenteral Antibiotic Therapy Clinic in Indonesia
by: Aryono Hendarto, et al.
Published: (2020-04-01)

Ceftriaxone‐associated pseudolithiasis
by: Masaru Kurihara, et al.
Published: (2021-09-01)

Successful outpatient management of pelvic actinomycosis by ceftriaxone: a report of three cases
by: Eda Demir Onal, et al.

Opportunities of Amlodipine as a Potential Candidate in the Evaluation of Drug Compliance during Antihypertensive Therapy
by: Dmitrijs Kustovs, et al.
Published: (2023-02-01)

Physicochemical equivalence studies of two amlodipine tablet formulations
by: Kecman Sanja, et al.
Published: (2018-01-01)

Surgical site infection in Nigerian patients: A comparative study of two prophylactic antibiotics
by: George Okwudilichukwu Enweluzo, et al.
Published: (2023-01-01)

The contribution of nano‐based strategies in overcoming ceftriaxone resistance: a literature review
by: Ashagrachew Tewabe, et al.
Published: (2021-08-01)

Differentiated approach to the choice of PPI in a patient with GERD in the practice of an outpatient (with a clinical case)
by: I. G. Pakhomova, et al.
Published: (2020-10-01)

Pharmacological correction of cerebrovascular disorders in various experimental pathological conditions
by: Ruben S. Mirzoyan, et al.
Published: (2018-03-01)

Cytoprotective Actions of Omeprazole in Indomethacin – Induced Gastric Mucosal Injury in Rats.
by: Mohammed J. Manna, et al.
Published: (2010-04-01)

Early effect of oral administration of omeprazole with mosapride as compared with those of omeprazole alone on the intragastric pH
by: Iida Hiroshi, et al.
Published: (2012-03-01)

Gestão das inovações incrementais, o caso Omeprazola Management of incremental innovations, the case Omeprazole
by: Alexandre Lopes Lourenço, et al.
Published: (2010-01-01)

Therapeutic usage of omeprazole and corticoid in a dog with hydrocephalus unresponsive to conventional therapy<br>Uso terapêutico da associação do omeprazol com corticóide em um cão com hidrocefalia não-responsiva ao tratamento convencional
by: Alexandre Mendes Amude, et al.
Published: (2013-05-01)

Uso do omeprazol: estudo descritivo de pacientes idosos de uma Unidade de Saúde da Família (USF) de Ribeirão Preto, SP, Brasil
by: Jean Mozart de LIMA, et al.
Published: (2019-04-01)

NOVEL PROTECTIVE ROLE OF MONTELUKAST AGAINST ASPIRIN INDUCED GASTRIC ULCERATION IN RABBITS - MONTELUKAST; A REVOLUTIONARY ASPECT
by: Syeda Urooj Zaidi, et al.
Published: (2020-09-01)

A Retrospective Study to Assess the Effect of Proton Pump Inhibitors on Renal Profile in a South Indian Hospital
by: A. Avinash, et al.
Published: (2017-04-01)

Seguridad del omeprazol: ¿es adecuada la duración de los tratamientos?
by: Carranza Caricol F.
Published: (2015-03-01)

Omeprazole-induced galactorrhea in kidney transplant patients—a case report
by: Choki Dorji, et al.
Published: (2022-03-01)

Once-a-Day Ceftriaxone–Amikacin Combination as Empiric Antibiotic Therapy to Enable Outpatient Management of Febrile Neutropenia in Children—16-Year Experience from a Single Institute
by: Shailesh Kanvinde, et al.
Published: (2022-10-01)

Comparative Study of High Dose Mono-Therapy of Amlodipine or Telmisartan, and Their Low Dose Combination in Mild to Moderate Hypertension
by: Jaswant Goyal, et al.
Published: (2014-06-01)

Endotoxin-Induced Sepsis on Ceftriaxone-Treated Rats’ Ventilatory Mechanics and Pharmacokinetics
by: Juliana Savioli Simões, et al.
Published: (2024-01-01)

Anaphylaxis to Ceftriaxone – Evaluation of Two Cases
by: Rozeeta Hirachan, et al.
Published: (2018-12-01)

Water transport through rat colonic epithelium during ceftriaxone therapy
by: T. Dovbynchuk, et al.
Published: (2016-07-01)

Ceftriaxone-induced encephalopathy in a patient with a solitary kidney
by: Yuya Futagi, et al.
Published: (2022-09-01)

7-{[2-(4-Hydroxyphenyl)methylidene]amino}-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
by: Ghulam Fareed, et al.
Published: (2012-05-01)

Comparison of prevalence of hypercalciuria after intravenous injection of ceftriaxone versus ampicillin and cefotaxime in children with febrile infection
by: Maryam Esteghamati, et al.
Published: (2019-03-01)

Gatifloxacin in the treatment of community-acquired pneumonias: a comparative trial of ceftriaxone, with or without macrolides, in hospitalized adult patients with mild to moderately severe pneumonia
by: J.S. Mendonça, et al.

The Dark Purple Side of Ceftriaxone: A Case Report on Leucocytoclastic Vasculitis
by: Elia Rigamonti, et al.
Published: (2020-03-01)

Ceftriaxone-associated pseudolithiasis in hemodialysis patients: a case series study
by: Yuko Oyama, et al.
Published: (2021-02-01)

Ceftriaxone-Resistant Neisseria gonorrhoeae, Canada, 2017
by: Brigitte Lefebvre, et al.
Published: (2018-02-01)